Moving new vaccines for tuberculosis through the regulatory process.
Where this comes from
- Record sourced from PubMed, PMID 10875792.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development of novel vaccines for the prevention of tuberculosis is an area of intense interest for scientific researchers, public health agencies, and pharmaceutical manufacturers. Development of effective new vaccines directed against tuberculosis for use in target populations will require close cooperation among several different international organizations, including regulatory agencies responsible for evaluating the safety and effectiveness of new biologics for human use.
Medical subject headings
- BCG Vaccine
- Bacterial Vaccines
- Drug Approval
- Mycobacterium tuberculosis
- Tuberculosis, Pulmonary